Association Between Immune-Mediated Adverse Events And Survival In Patients With Metastatic Non-Small Cell Lung Cancer Treated With Durvalumab And Tremelimumab.
CANCER RESEARCH(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
CANCER RESEARCH(2021)